We are live on ! Find out more
ARMP icon

Armata Pharmaceuticals
ARMP

19 hedge funds and large institutions have $5.25M invested in Armata Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0.66% less ownership

Funds ownership: 4.4% → 3.74% (-0.66%)

5% less funds holding

Funds holding: 20 → 19 (-1)

21% less capital invested

Capital invested by funds: $6.61M → $5.25M (-$1.36M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$4.83K
2
SWM
SeaCrest Wealth Management
New York
+$3.69K
3
UBS Group
UBS Group
Switzerland
+$1.69K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.33K
5
Bank of America
Bank of America
North Carolina
+$1.03K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$13.1K
2
Renaissance Technologies
Renaissance Technologies
New York
-$7.38K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
1
Bank of America
North Carolina
$2.47M +$1.03K +237 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.06M – – –
BCM
3
Bridgeway Capital Management
Texas
$442K – – –
Edgewood Management
4
Edgewood Management
Connecticut
$389K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$311K -$7.38K -1,700 -2%
SF
6
Synovus Financial
Georgia
$187K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$87K +$1.33K +307 +1%
BlackRock
8
BlackRock
New York
$84K -$13.1K -3,025 -12%
Northern Trust
9
Northern Trust
Illinois
$75K – – –
SWM
10
SeaCrest Wealth Management
New York
$68K +$3.69K +850 +5%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$51K – – –
UBS Group
12
UBS Group
Switzerland
$12K +$1.69K +390 +14%
Morgan Stanley
13
Morgan Stanley
New York
$4K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$4K +$4.83K +1,113 New
CAPTRUST Financial Advisors
15
CAPTRUST Financial Advisors
North Carolina
$2K – – –
Northwestern Mutual Wealth Management
16
Northwestern Mutual Wealth Management
Wisconsin
$2K – – –
Fidelity Investments
17
Fidelity Investments
Massachusetts
– -$1K -285 Closed
Wells Fargo
18
Wells Fargo
California
– +$26 +6 +8%

ARMP Hedge Fund Activity: Q2 2022 in Review

19 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q2 2022, worth a combined $5.25M — down 21% from $6.61M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ARMP and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $4.83K. The largest seller was BlackRock, cutting an estimated $13.1K.

  • 19 institutional investors held Armata Pharmaceuticals (ARMP) as of Q2 2022, down from 20 in Q1 2022.
  • Funds reported $5.25M of Armata Pharmaceuticals stock for Q2 2022, down 21% quarter-over-quarter.
  • 1 fund opened new Armata Pharmaceuticals positions in Q2 2022 and 2 closed out, a net change of -1 holder.
  • The largest Armata Pharmaceuticals buyer in Q2 2022 was Tower Research Capital (TRC), an estimated $4.83K added.
  • The largest Armata Pharmaceuticals seller in Q2 2022 was BlackRock, an estimated $13.1K sold.

Based on aggregated 13F filings for Q2 2022.